Referrals for Newly Diagnosed or T2DM Patients With Inadequate Glycemic Control for Phase III Clinical Trial
Dear Colleague, With the rise of type 2 diabetes (T2DM) amongst pediatric patients, it is imperative to expand safe and effective treatment options. We are currently participating as investigators for a Phase III sitagliptin research study for pediatric patients with T2DM. As an investigator, we would like to ask for your help with patient referrals.…